Kenneth Wang MD

Kenneth Wang, MD, MPH, is an Executive Director in Oncology Clinical Safety and Risk Management at Merck, where they have been since 2023. With over 18 years of experience in the pharmaceutical industry, they have held key positions at Bristol-Myers Squibb, Pfizer, and Amgen, contributing to oncology clinical development and pharmacovigilance. Kenneth has demonstrated expertise in patient safety and risk assessment, regulatory submissions, and global regulatory approvals. They earned a BS in Biology from the University of Michigan, an MD from the University of Pennsylvania School of Medicine, and an MPH in Quantitative Methods from Harvard.